Skip to main content
TT&A, Farooq and Associates advise IFC on $30 million to Popular Pharma
Back to Court News
N/Acorporate

TT&A, Farooq and Associates advise IFC on $30 million to Popular Pharma

July 24, 2026

TT&A and Farooq and Associates facilitated a $30.7 million financing deal from the International Finance Corporation to Popular Pharmaceuticals PLC. This significant funding aims to bolster the pharmaceutical sector in Bangladesh.

TT&A and Farooq and Associates Advise IFC on $30 Million Financing

The International Finance Corporation (IFC) is set to provide a substantial loan of up to $30.7 million to Popular Pharmaceuticals PLC, a prominent company based in Bangladesh. This financing transaction was executed with the advisory support of TT&A and Farooq and Associates.

The experienced team from TT&A included Managing Partner Gautam Saha, Partner Nikhil Bahl, Managing Associate Ankita Mandal, and Associate Manasvini Vyas. The firm has previously engaged in similar financing arrangements for companies in Bangladesh, indicating a strong portfolio in supporting the region's economic growth.

This loan aims to enhance the operational capacity of Popular Pharmaceuticals, illustrating the growing potential of the Bangladeshi pharmaceutical industry as a key market in South Asia. Such investments are critical in enabling local companies to scale while complying with international standards.

For legal practitioners, this transaction exemplifies the complexities involved in cross-border finance and the importance of legal guidance to navigate local regulatory landscapes, ensuring compliance while attracting international investment.

Source:N/A
Practice Areas:corporate